CSPC Pharmaceutical Group's (HKG:1093) SYS6090 (JMT108) was granted Fast Track designation by the U.S. Food and Drug Administration (FDA).
The designation is for the treatment of patients with metastatic colorectal cancer, according to a Wednesday Hong Kong bourse filing.